Consumer Healthcare Market
Consumer healthcare products are non-prescription drugs such as pain killers, acne therapy, hair care, cold and allergy remedies. In addition, consumer healthcare products include nutraceutical products such as vitamins, proteins, and minerals. These consumer healthcare products do not require the medical practitioner prescription and may be sold through pharmacies as well as retail stores.
Allied Market Research published a report, titled, “Consumer healthcare Market By Product (OTC Pharmaceuticals, Personal Care Products And dietary supplements.), By Distribution Channel (Online And Offline): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global consumer healthcare market was valued at $280.1 billion in 2022, and is projected to reach $574.4 billion by 2032, registering a CAGR of 7.5% during 2023 to 2032.
An increase in demand for dietary supplements, the growing trend of self-medication, and an increase in the number of key players drive the growth of the global Consumer healthcare market. However, stringent government regulations may restrict the market growth. Moreover, a rise in the number of key players and developing economies presents new opportunities in the coming years.
Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3511
Market Segmentation
Based on the Product:
The OTC Pharmaceuticals segment held the highest market share in 2022, accounting for nearly of the global consumer healthcare market revenue and is estimated to maintain its leadership status throughout the forecast period. The increase in the adoption of OTC Pharmaceuticals by consumers is the major factor that propels the growth of the OTC Pharmaceuticals segment across the globe. In addition, an increase in the number of key players drives the segment. However, the Dietary Supplements segment is projected to manifest the highest CAGR of 7.8% from 2023 to 2032. This is due to its popularity in the U.S., Canada, and Western European countries.
Based on Distribution Channel:
The Offline segment held the highest market share in 2022, accounting for more than four-fifths of the global consumer healthcare market revenue and is estimated to maintain its leadership status throughout the forecast period. However, the Online segment is projected to manifest the highest CAGR of 7.9% from 2023 to 2032, owing to the rise in the adoption of e-commerce services.
By Region:
North America held the highest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global consumer healthcare market revenue and is likely to dominate the market during the forecast period. The increase in the adoption of e-commerce services contributes to the growth of the consumer healthcare market in North America. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.9% from 2023 to 2032. The rise in demand for dietary supplements, owing to the presence of high-potential markets such as India and China, is expected to drive the growth of the consumer healthcare market across the province.
Leading Market Players:
- Johnson & Johnson
- Sanofi
- Pfizer Inc.
- Abbott Laboratories
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Amway
- BASF SE.
𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
Microsurgery Market is growing at a CAGR of 6% from 2024 to 2033
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
